Back to Search
GREGORY OTTERSON, M.D.
M.D.
Medical Oncology Physician
NPI: 1215945548Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs.
PMID 17317836·Clin Cancer Res·2007
3-trial
A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors.
PMID 16034523·Invest New Drugs·2005
3-trial
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
PMID 15084390·Lung Cancer·2004
3-trial
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.
PMID 19506871·Cancer Chemother Pharmacol·2010
8-other
A psychometric analysis of quality of life tools in lung cancer patients who smoke.
PMID 19181418·Lung Cancer·2009
4-observational
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.
PMID 19654003·Biochem Biophys Res Commun·2009
8-other
Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice.
PMID 19440353·PLoS One·2009
7-preclinical
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
PMID 18795290·Cancer Chemother Pharmacol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 460 W 10TH AVE
COLUMBUS, OH 43210 - Phone
- (614) 293-6529
Quick Facts
- NPI
- 1215945548
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile